- Home
- Hypertrophic Cardiomyopathy in Review
Hypertrophic Cardiomyopathy in Review
HCM in Review: Highlights of 2022
- 0.25
Published:
Learning objectives
- Recall the efficacy and safety of existing HCM treatments
- Summarise results from ongoing trials with experimental treatments
HCM in Review: Assessing SCD Risk in HCM & Managing HCM With High Risk SCD
- 0.50
Published:
Learning objectives
- Recall risk factors associated with sudden cardiac death (SCD)
- Recall best practice approaches to prevent SCD according to guidelines and expert insight
- Stratify patients likely to benefit from invasive procedures versus pharmacological treatment
HCM in Review: ESC–HFA 2022 & How to Differentiate HCM From Its Phenocopies
- 0.50
Published:
Learning objectives
- Recall the efficacy and safety of existing HCM treatments and summarise results from ongoing trials with experimental treatments
- Differentiate the signs and symptoms of HCM from other conditions that frequently mask, or mimic the disease and in the presence of comorbidities
HCM in Review: Highlights of ACC 2022
- 0.25
Published:
Learning objectives
- Recall the efficacy and safety of existing HCM treatments
- Summarise results from ongoing trials with experimental treatments
Hypertrophic Cardiomyopathy: Application of Emerging Data and Genetic Testing in Clinical Practice
- 0.75
Published:
Learning objectives
- Recall the efficacy and safety of existing HCM treatments
- Summarise results from ongoing trials with experimental treatments
- Stratify individuals with HCM signs and symptoms for subsequent investigation and/or genetic screening
Hypertrophic Cardiomyopathy in Review: Highlights from HFA 2021
- 0.50
Published:
Learning objectives
- Identify patients likely to benefit from invasive procedures versus pharmacological treatment
- Stratify individuals with HCM signs and symptoms for subsequent investigation and/or genetic screening